RSS

Opinion

GlobalData, a data and analytics company, has reported that further development of chimeric antigen receptor (CAR)-T cell therapies in solid tumours will require collaboration with industry. more

Analysis

A stark warning that ‘innovation is being hindered by regulators’ has been given by the president of EPCOT International, Girish Malhotra, in the first part of CPhI Worldwide’s sixth annual report. more

Analysis

Amazon

Eric Broder Van Dyke / Shutterstock.com

According to data and analytics company, GlobalData, Amazon is poised to make huge strides within healthcare as its business model offers easier connectivity between providers and patients and it has a powerful online platform... more

News

According to poll results from Pew Research Center, the American public is accepting of gene editing in animals that could benefit human health, potentially removing a barrier to research, as noted by a pharma analyst at GlobalData. more

Opinion

Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence. more

Opinion

In this online exclusive, Erik Janssen, vice president of Global New Patient Solutions Neurology at UCB, talks about why advancements in big data and analytics might be the key to helping patients with epilepsy. more

Opinion

Dr Stuart Ward, head of business analysis at IDBS, discusses why organisations should be considering transitioning to cloud-based software and technologies and some of the important things they should keep in mind. more

Opinion

Bryan Plaster, VP Customer Services at Trifacta, tells us more about how establishing a centre of excellence (CoE) for data analytics can help organisations accelerate research & development (R&D). more

Opinion

We have now passed the six month point before the Falsified Medicines Directive (FMD) comes into force. In this online exclusive, Mark Davison, senior operations director, rfxcel insists you ACT NOW! Here are six short reflections. more

Opinion

Here, Rich Quelch, global head of marketing, Origin, looks at the challenges involved in primary packaging and delivery systems for biologics. more

Opinion

Here, Justin Schroeder, senior executive director of Global Marketing and Design at PCI Pharma Services, looks at patient centricity in pharmaceuticals and how it may help with medication adherence. more

Opinion

In response to the government’s Home Affairs Committee’s report on policy options for the future migration from the European Economic Area, Dr Sarah Main, executive director of the Campaign for Science and Engineering (CaSE) gives us her thoughts more

Opinion

The pathway to value: walking in your customers’ shoes David Southern, managing director, Spirit Access, discusses how a more patient-focused pathway to designing services is more likely the successful one and how companies can achieve this. more

Opinion

Here, in this online exclusive, Kalik looks at the need for a change in work culture and implementing new systems and procedures to make a more productive workplace. more

Opinion

Here, Declan Maguire, operations director, Celtic Anglian Water & Alpheus Environmental, discusses how to future-proof in this increasingly strict area through outsourcing. more

Opinion

As the race to dominate the artificial intelligence (AI) space steps up a gear, I take a look at how AI finds use in pharma and how different regions plan to invest in this exciting area. more

Opinion

In this online exclusive, Alex Aves, marketing executive, Rephine, looks at blockchain in more detail including how it may benefit the pharmaceutical sector. more

Opinion

Jon Lant, head of New Product Development & Innovation, Origin explores how the pharma packaging industry is innovating to keep ahead of the curve, to protect profit margins and meet the ever-growing expectations of stakeholders. more

Opinion

The ‘Amazon Effect’, new address systems and Brexit are driving change, in this online opinion article, BluJay Solutions presents the three most important trends to prepare for in 2018. more

Opinion

In this article, Hervé Sibillat, general manager, ADM-SIO, discusses the important considerations in managing the natural variability of plant-based pharmaceutical ingredients. more

Opinion